These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 17477859

  • 41. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
    Chen AY, Jemal A, Ward EM.
    Cancer; 2009 Aug 15; 115(16):3801-7. PubMed ID: 19598221
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Age-related lobular involution and risk of breast cancer.
    Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1600-7. PubMed ID: 17105983
    [Abstract] [Full Text] [Related]

  • 44. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK.
    Breast Cancer Res Treat; 2011 Jul 15; 128(2):483-93. PubMed ID: 21225455
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES.
    Ann Surg Oncol; 2007 Feb 15; 14(2):695-703. PubMed ID: 17103262
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B.
    Cancer Causes Control; 2010 Feb 15; 21(2):275-82. PubMed ID: 19894130
    [Abstract] [Full Text] [Related]

  • 49. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):121-31. PubMed ID: 19124489
    [Abstract] [Full Text] [Related]

  • 50. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme.
    Ascunce EN, Moreno-Iribas C, Barcos Urtiaga A, Ardanaz E, Ederra Sanz M, Castilla J, Egüés N.
    J Med Screen; 2007 Jan 15; 14(1):14-20. PubMed ID: 17362566
    [Abstract] [Full Text] [Related]

  • 51. Breast carcinoma survival in Europe and the United States.
    Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Møller H, Paci E, Raverdy N, Tretarre B, Williams EM, European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group.
    Cancer; 2004 Feb 15; 100(4):715-22. PubMed ID: 14770426
    [Abstract] [Full Text] [Related]

  • 52. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data.
    Hock LM, Lynch J, Balaji KC.
    J Urol; 2002 Jan 15; 167(1):57-60. PubMed ID: 11743275
    [Abstract] [Full Text] [Related]

  • 53. Breast cancer in New Zealand: trends, patterns, and data quality.
    Armstrong W, Borman B.
    N Z Med J; 1996 Jun 28; 109(1024):221-4. PubMed ID: 8769030
    [Abstract] [Full Text] [Related]

  • 54. [Time trends in cancer incidence in Osaka].
    Hanai A, Fujimoto I.
    Gan To Kagaku Ryoho; 1984 Mar 28; 11(3):367-76. PubMed ID: 6703715
    [Abstract] [Full Text] [Related]

  • 55. Trends in the incidence of invasive and in situ vulvar carcinoma.
    Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA.
    Obstet Gynecol; 2006 May 28; 107(5):1018-22. PubMed ID: 16648405
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
    Viel JF, Rymzhanova R, Fournier E, Danzon A.
    Cancer Epidemiol; 2011 Dec 28; 35(6):521-5. PubMed ID: 21621498
    [Abstract] [Full Text] [Related]

  • 58. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data.
    Gnerlich J, Dueker JM, Jeffe DB, Deshpande AD, Thompson S, Margenthaler JA.
    Breast J; 2008 Dec 28; 14(6):538-42. PubMed ID: 19000055
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
    Sharpe KH, McClements P, Clark DI, Collins J, Springbett A, Brewster DH.
    Eur J Cancer; 2010 Mar 28; 46(5):937-43. PubMed ID: 20122823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.